Search Results - "Silveira, Pablo A"
-
1
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
Published in Frontiers in immunology (07-06-2019)“…CD83 is a member of the immunoglobulin (Ig) superfamily and is expressed in membrane bound or soluble forms. Membrane CD83 (mCD83) can be detected on a variety…”
Get full text
Journal Article -
2
A Subset of Interleukin-21 + Chemokine Receptor CCR9 + T Helper Cells Target Accessory Organs of the Digestive System in Autoimmunity
Published in Immunity (Cambridge, Mass.) (22-04-2011)“…This study describes a CD4 + T helper (Th) cell subset marked by coexpression of the cytokine interleukin 21 (IL-21) and the gut-homing chemokine receptor…”
Get full text
Journal Article -
3
Anti-Mouse CD83 Monoclonal Antibody Targeting Mature Dendritic Cells Provides Protection Against Collagen Induced Arthritis
Published in Frontiers in immunology (10-02-2022)“…Antibodies targeting the activation marker CD83 can achieve immune suppression by targeting antigen-presenting mature dendritic cells (DC). This study…”
Get full text
Journal Article -
4
Dihydrotestosterone (DHT) Enhances Wound Healing of Major Burn Injury by Accelerating Resolution of Inflammation in Mice
Published in International journal of molecular sciences (28-08-2020)“…Androgens have been known to inhibit cutaneous wound healing in men and male mice. However, in children with major burn injuries, a synthetic androgen was…”
Get full text
Journal Article -
5
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
Published in Haematologica (Roma) (01-04-2018)“…Chemotherapy and hematopoietic stem cell transplantation are effective treatments for most Hodgkin lymphoma patients, however there remains a need for better…”
Get full text
Journal Article -
6
Examination of CD302 as a potential therapeutic target for acute myeloid leukemia
Published in PloS one (10-05-2019)“…Acute myeloid leukemia (AML) is the most common form of adult acute leukemia with ~20,000 new cases yearly. The disease develops in people of all ages, but is…”
Get full text
Journal Article -
7
On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy
Published in Frontiers in oncology (06-02-2019)“…Monoclonal antibodies targeting co-inhibitory immune checkpoint molecules have been successful in clinical trials of both solid and hematological malignancies…”
Get full text
Journal Article -
8
CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation
Published in Molecular oncology (01-10-2019)“…Antibody‐based therapy in acute myeloid leukemia (AML) has been marred by significant hematologic toxicity due to targeting of both hematopoietic stem and…”
Get full text
Journal Article -
9
The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self‐antigen‐specific immunoglobulin receptors
Published in European journal of immunology (01-12-2002)“…B lymphocytes partially contribute to autoimmune type 1 diabetes (T1D) as a subset of APC with a preferential ability to trigger pathogenic CD4 T cells. We…”
Get full text
Journal Article -
10
Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia
Published in Blood advances (14-04-2020)“…Allogeneic hematopoietic stem cell transplantation (allo-HSCT) significantly reduces the rate of relapse in acute myeloid leukemia (AML) but comes at the cost…”
Get full text
Journal Article -
11
Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody
Published in Clinical & translational immunology (2020)“…Objectives Effective antibody–drug conjugates (ADCs) provide potent targeted cancer therapies. CD83 is expressed on activated immune cells including B cells…”
Get full text
Journal Article -
12
The cell surface phenotype of human dendritic cells
Published in Seminars in cell & developmental biology (01-02-2019)“…Dendritic cells (DC) are bone marrow derived leucocytes that are part of the mononuclear phagocytic system. These are surveillance cells found in all tissues…”
Get full text
Journal Article -
13
B-cell tolerance: mechanisms and implications
Published in Current opinion in immunology (01-10-2010)“…Advances in our knowledge of the spectrum of B-cell activities combined with the remarkable clinical efficacy of B-cell inhibitors in autoimmunity and…”
Get full text
Journal Article -
14
B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling
Published in Current Opinion in Immunology (01-06-2007)“…B-cell activation factor from the tumor necrosis factor family (BAFF) is a key survival factor during B-cell maturation — a delicate immune checkpoint for B…”
Get full text
Journal Article -
15
Tropoelastin modulates systemic and local tissue responses to enhance wound healing
Published in Acta biomaterialia (01-08-2024)“…Wound healing is facilitated by biomaterials-based grafts and substantially impacted by orchestrated inflammatory responses that are essential to the normal…”
Get full text
Journal Article -
16
CD300f signalling induces inhibitory human monocytes/macrophages
Published in Cellular immunology (01-08-2023)“…•CD300f signalling on human monocytes/macrophages increases PD-L1 expression.•CD300f activates Akt/PI3K on human monocytes.•CD300f induces immune suppressive…”
Get full text
Journal Article -
17
Cellular Expression Requirements for Inhibition of Type 1 Diabetes by a Dominantly Protective Major Histocompatibility Complex Haplotype
Published in Diabetes (New York, N.Y.) (01-02-2007)“…Cellular Expression Requirements for Inhibition of Type 1 Diabetes by a Dominantly Protective Major Histocompatibility Complex Haplotype Yi-Guang Chen 1 ,…”
Get full text
Journal Article -
18
B cell-directed therapies in type 1 diabetes
Published in Trends in immunology (01-06-2011)“…B cells play a pathogenic role as antigen-presenting cells and autoantibody secretors in the lead up to T cell-mediated autoimmune destruction of…”
Get full text
Journal Article -
19
Invasion of the killer B's in type 1 diabetes
Published in Frontiers in bioscience (01-01-2007)“…Type 1 Diabetes (T1D) is an autoimmune disease requiring contributions from effectors in both CD4+ and CD8+ T cell compartments in order to destroy insulin…”
Get full text
Journal Article -
20
The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population
Published in The Journal of immunology (1950) (15-12-2016)“…CD83 is a member of the Ig gene superfamily, first identified in activated lymphocytes. Since then, CD83 has become an important marker for defining activated…”
Get full text
Journal Article